01.13.2020

The Future of RWE Arrives

01.13.2020
The Future of RWE is Here

Concerto HealthAI is revolutionizing the combination of data and AI to get the right medicines to the right patients faster

Delivering high-performance RWE

eurekaHealth 3.0: The first and only integrated data and AI solution for the enterprise

Read the Press Release

Becoming the
industry standard

Janssen and Pfizer sign on for eurekaHealth collaboration

Read the Press Release

Driving next-gen
innovation

$150M raise to power
breakthrough capabilities

Read the Press Release

Accelerating patient insights

Precision Health Informatics partnership advances cancer testing and treatment

Read the Press Release

The System of Intelligence for Precision Oncology

Powerful Real-World Data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients.

For Life Sciences

Enterprise AI technology solutions support innovative new approaches to RWE studies and a wide variety of research applications.

Explore Our Solutions

For Providers

Insights into clinical variability, patient-reported outcomes, and integration of clinical research into clinical workflows to help patient-centered, precision oncology.

Explore Our Solutions

Latest Updates

ISPOR Image-5

Concerto HealthAI Research Accepted for Poster Presentation at ISPOR 2020

Performance of time to discontinuation and time to next treatment as proxy measures compared to direct observation of progression-free survival (PFS)

The study demonstrates that direct measurement of critical endpoints like PFS significantly improves outcomes analyses, compared to using traditional proxy measures like TTD and TTNT which can significantly underestimate PFS.

Read More